A Randomized controlled trial of modified Respiratory Guixinggong in delaying the progression of Pulmonary dysfunction in patients with mild to moderate COPD

Phase 1

Recruiting

• Conditions: Chronic obstructive pulmonary disease

• Registration Number: ITMCTR2000004077
• Lead Sponsor: Affiliated Hospital of Chengdu University of traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-02-20

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. patients aged 45-75 years with mild to moderate COPD in stable stage;
2. meet the diagnostic criteria: FEV1/FVC < 70% after using bronchodilator, and FEV1 >=50% after using bronchodilator, with a history of respiratory symptoms and / or risk factors exposure;
3. one month or more after acute attack treatment;
4. did not participate in other traditional exercise before being selected;
5. voluntarily participated in this study with informed consent and signed informed consent form;
6. those with clear consciousness and stable cardiopulmonary function.

Exclusion Criteria

1. patients with chronic cough and wheezing caused by tuberculosis, fungus, tumor, irritant gas, allergy and other factors; and patients diagnosed as bronchial asthma, bronchiectasis, lung cancer, congestive heart failure, bronchiolitis obliterans, diffuse panbronchiolitis, bronchial keratosis, etc.;
2. patients with cardiovascular, urinary, digestive, blood, endocrine and other serious primary diseases and inability to cooperate with spirit, intelligence or even thinking;
3. pregnant or lactating women;
4. patients who are participating in other clinical trials;
5. researchers believe that other reasons are not suitable for clinical trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified